Vitamin C: A stem cell promoter in cancer metastasis and immunotherapy - 28/10/20
, Tianfu Wu ⁎ 
| pagine | 7 |
| Iconografia | 3 |
| Video | 0 |
| Altro | 0 |
Graphical abstract |
Highlights |
• | Vitamin C depresses cancer stem cells at a high concentration. |
• | Vitamin C can affect ECM remodeling and regulate cancer metastasis indirectly. |
• | Vitamin C prevents hypoxia-inducible factor (HIF-1) activation, which plays an integral role in inducing angiogenesis. |
• | Vitamin C represses PD-L1 stability by activating TET2 in anti-PD-L1 treatments. |
Abstract |
Vitamin C is an electron donor and is involved in a variety of biochemical reactions in stem cell and cancer stem cell, as well as collagen synthesis and the regulation of hypoxia-inducible factor synthesis, which two affect extracellular matrix remodelling and hence cancer metastasis. Specific doses of vitamin C can stop cancer cell glycolysis and block nitroso synthesis, indicating the potential of vitamin C in cancer treatment. Recent studies preliminary revealed Vitamin C enhance the cancer’s immune response to anti PD-L1 therapy through multiple indirect approaches. Herein we reviewed the recent function of vitamin C for further research in sequential aspects of cancer stem cell, extracellular matrix remodeling, cancer metastasis and cancer immunotherapy.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Vitamin C, Cancer metastasis, Cancer therapy, Hypoxic induction factory, Immune system, Extracellular matrix remodeling
Mappa
Vol 131
Articolo 110588- novembre 2020 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
